{"filing":{"accession_number":"0001022079-26-000097","cik":"0001022079","ticker":"DGX","company_name":"QUEST DIAGNOSTICS INC","form":"8-K","filing_date":"2026-10-22","report_date":"2026-10-22","primary_document":"dgx-20261022.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207926000097/dgx-20261022.htm"},"events":[{"id":36992,"run_id":34094,"accession_number":"0001022079-26-000097","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Quest Diagnostics issued a press release on October 22, 2026 announcing third quarter 2026 financial results, including Q3 revenues of $3.10 billion (up 10.0% YoY), diluted EPS of $2.78 (up 28.7% YoY), and adjusted diluted EPS of $3.00 (up 15.4% YoY). The company also raised full-year 2026 revenue and EPS guidance. This is a standard quarterly earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.","company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","filing_date":"2026-10-22","form":"8-K","submitted_at":null,"items":[{"id":41562,"accession_number":"0001022079-26-000097","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Quest Diagnostics issued a press release on October 22, 2026 announcing third quarter 2026 financial results, including Q3 revenues of $3.10 billion (up 10.0% YoY), diluted EPS of $2.78 (up 28.7% YoY), and adjusted diluted EPS of $3.00 (up 15.4% YoY). The company also raised full-year 2026 revenue and EPS guidance. This is a standard quarterly earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T10:50:40.100308+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41562,"accession_number":"0001022079-26-000097","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Quest Diagnostics issued a press release on October 22, 2026 announcing third quarter 2026 financial results, including Q3 revenues of $3.10 billion (up 10.0% YoY), diluted EPS of $2.78 (up 28.7% YoY), and adjusted diluted EPS of $3.00 (up 15.4% YoY). The company also raised full-year 2026 revenue and EPS guidance. This is a standard quarterly earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T10:50:40.100308+00:00","company_name":"QUEST DIAGNOSTICS INC","ticker":"DGX","filing_date":"2026-10-22"}]}